• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform

    Diagnostic Desperation: A Look at IVD Trends During COVID-19

    Resourceful Resources: Materials Make a Difference During the Pandemic

    Stressed Testing: Challenges with Medical Device Testing
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    EchoNous Expands Its Kosmos Hardware Platform

    Medtronic Begins Trial to Assess Novel Ablation Tech to Treat AFib

    Europe's Cross-Border Medtech Deal Activity Rises in Q4 2020

    Bio-Techne to Acquire Asuragen for $320M

    QUANTA Appoints Chief Operating Officer
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform

    Diagnostic Desperation: A Look at IVD Trends During COVID-19

    Resourceful Resources: Materials Make a Difference During the Pandemic

    Stressed Testing: Challenges with Medical Device Testing
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Cybersecurity Compromises, Courtesy of COVID-19

    A Look at the Actual Device Costs for Hospitals

    Show Time: Here’s What a Year of No Tradeshows Meant for Small Businesses

    FDA Making Progress With Technology and Data Action Plans

    What’s Hot Now in Medtech M&A
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Medbio LLC

    Medicoil

    maxon

    Spectrum Plastics Group

    Creganna Medical, part of TE Connectivity
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How Grant Funding Works and How It Can Help

    Refurbished Medical Equipment Testing and Certification Under the NEC

    Taking the First Step with Metal Components

    4 Trends Driving Medical Manufacturing in 2021

    Pioneering AI Solutions to Reinforce Healthcare Services
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    K-Tube Technologies

    PTI Engineered Plastics Inc.

    Spectrum Plastics Group

    Forefront Medical Technology

    maxon
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    FDA Approves Daytime Treatment for Sleep Apnea and Snoring

    Signifier Medical’s proprietary therapy eXciteOSA is the first and only daytime genioglossal (tongue) muscle-neurostimulation technology approved in the U.S.

    FDA Approves Daytime Treatment for Sleep Apnea and Snoring
    eXciteOSA. Image courtesy of Signifier Medical Technologies.
    Related CONTENT
    • Requirements and Impact of the New Guideline- ISO 10993-23: Tests for Irritation
    • The Many Hats of an Integrated Contract Manufacturer
    • Medtronic Begins Trial to Assess Novel Ablation Tech to Treat AFib
    • NAMSA Acquires American Preclinical Services
    • Memic Receives FDA Marketing Authorization for Hominis
    Michael Barbella, Managing Editor02.23.21
    Patients suffering from sleep apnea no longer have to wait until bedtime to treat their condition.

    The U.S. Food and Drug Administration (FDA) has approved the first-ever daytime treatment for mild obstructive sleep apnea and snoring. Signifier Medical Technologies, a developer of sleep disordered breathing technology, recently received FDA approval of its eXciteOSA, an intraoral neuromuscular stimulation device for treating mild obstructive sleep apnea and snoring. Used for only 20 minutes per day for a period of six weeks and then twice per week, the therapy is clinically proven to improve the quality of sleep by significantly reducing obstructive sleep apnea and snoring.1-4
      
    Unlike devices used while patients sleep, eXciteOSA is the first device used while awake that is intended to improve tongue muscle function, targeting the root causes of these conditions. 
     
    In a study of 65 mild obstructive sleep apnea patients, 79 percent of patients responded to therapy with a mean reduction of 52 percent in AHI (Apnea Hypopnea Index), a 50 percent reduction in ODI (Oxygen Desaturation Index), and a 3.9 point reduction in ESS (Epworth Sleepiness Scale). In the pivotal study of the device, eXciteOSA exceeded the targeted endpoint of a 20 percent mean reduction in snoring time, achieving nearly a 40 percent mean reduction in snoring time across 115 patients.
     
    “We are thrilled that this groundbreaking treatment will soon be available in the U.S., offering an entirely unique, simple, and comfortable solution that has the potential to improve the lives of millions of people,” said Akhil Tripathi, CEO and co-founder of Signifier Medical Technologies. “Restful sleep is critically important, yet for too many it is out of grasp because they or their partner suffer from a sleep disorder. We look forward to launching this revolutionary new option to select markets in the coming weeks.”
     
    Obstructive sleep apnea and snoring affect one in three people – as many as 110 million Americans. Left untreated, obstructive sleep apnea can lead to serious complications such as hypertension, heart attack, glaucoma, diabetes, cancer, and cognitive and behavioral disorders.
     
    “Treatment of sleep apnea has been shown to be highly effective for patients as there is growing evidence that it improves symptoms, reduces blood pressure, improves glucose control, and reduces the risk of motor vehicle accidents, among other benefits. A strong argument can be made that early treatment may be beneficial since the consequences of the condition may become irreversible,” said Atul Malhotra, M.D., research chief, Pulmonary, Critical Care and Sleep Medicine at UC San Diego Health, who served as a clinical trial investigator for the eXciteOSA device. “I believe that eXciteOSA will be an important treatment approach for patients with snoring and mild sleep apnea and look forward to offering it to my patients.”
     
    Signifier Medical has developed a digital OSA therapy interface for patients and clinicians, which includes an intuitive app for use alongside the eXciteOSA device. The app is designed to give personalized care and motivate patients to achieve high therapy adherence. A “light touch design” with no fitting required, the eXciteOSA system includes digital connectivity between patient, bed partner, and provider to enable virtual setup, remote monitoring, and an overall exceptional patient experience.
     
    “The FDA approval for eXciteOSA is great news for OSA patients. This novel device will bring benefit to a neglected cohort of the sleep disordered breathing condition, namely those with mild obstructive sleep apnea,” said Peter Cistulli, M.D., professor of Respiratory Medicine and Head of the Discipline of Sleep Medicine at the University of Sydney, and Head of the Department of Respiratory and Sleep Medicine at Royal North Shore Hospital.
     
    Nearly 1 billion adults aged 30 to 69 years are estimated to have obstructive sleep apnea (OSA) globally. There is a strong, clinically proven link between OSA and co-morbidities like diabetes, hypertension, and strokes. Mild OSA affects over 110 million people in the United States and 100 million people in Europe.
     
    Obstructive sleep apnea is marked by the recurring collapse of the upper airways during sleep. The most common symptoms are restless sleep, snoring, tiredness during the day, decreased intellectual alertness, and personality alterations. Higher risks of cardiovascular diseases and increased mortality rates have been associated with OSA.
     
    Standard therapy of all advanced levels of sleep apnea is with a continuous positive airway pressure (CPAP) device. Many patients find this therapy invasive, and the long-term compliance of CPAP therapy is limited, so there is a clear demand for new forms of treatment.
     
    Signifier’s proprietary therapy eXciteOSA is the first and only daytime genioglossal (tongue) muscle-neurostimulation technology approved in the United States for mild obstructive sleep apnea and snoring and is supported by clinical data from prestigious and well-recognized universities and academic institutions, that provides a safe and effective treatment for its patients.1-3

    References
    1 White DP. Sleep-related breathing disorder: 2—pathophysiology of obstructive sleep apnoea. Thorax. 1995; 50:797–804. [PubMed: 7570420]
    2 Wessolleck E, Bernd E, Dockter S, et al. Intraoral electrical muscle stimulation in the treatment of snoring. Somnologie (Berl). 2018; 22 (Suppl 2): 47–52.
    3 Sama A, et al. Daytime Intraoral Neurostimulation with eXciteOSA® for Treatment of Snoring and Mild Sleep Apnea. CHEST Annual Meeting Notes. 2018.
    4 Clinical study of 115 patients with snoring or mild OSA (Apnea-Hypopnea Index (AHI <15 n=65)). Objective snoring and respiratory parameters were recorded with 2 consecutive WatchPAT® night sleep studies before and after the use of the device. An intra-oral tongue stimulator (eXciteOSA®) device was used for 20 mins, once a day for a 6-week period.
    Suggested For You
    Requirements and Impact of the New Guideline- ISO 10993-23: Tests for Irritation Requirements and Impact of the New Guideline- ISO 10993-23: Tests for Irritation
    The Many Hats of an  Integrated Contract Manufacturer The Many Hats of an Integrated Contract Manufacturer
    Medtronic Begins Trial to Assess Novel Ablation Tech to Treat AFib Medtronic Begins Trial to Assess Novel Ablation Tech to Treat AFib
    NAMSA Acquires American Preclinical Services NAMSA Acquires American Preclinical Services
    Memic Receives FDA Marketing Authorization for Hominis Memic Receives FDA Marketing Authorization for Hominis
    FDA Breakthrough Device Designation Awarded to BrainCool AB FDA Breakthrough Device Designation Awarded to BrainCool AB's Cooral System
    Solid Growth Forecast for Japan Solid Growth Forecast for Japan's MI Neurosurgical Devices Market
    Medtech Matters: FDA’s Ambiguity on Hyaluronic Acid Medtech Matters: FDA’s Ambiguity on Hyaluronic Acid
    Mike on Medtech: Update on FDA Mike on Medtech: Update on FDA's STeP Designation
    FDA Clears Ava Fertility Tracking Wearable Device FDA Clears Ava Fertility Tracking Wearable Device
    First Patient in Europe Treated With Diamondback 360 Coronary Orbital Atherectomy System First Patient in Europe Treated With Diamondback 360 Coronary Orbital Atherectomy System
    Refurbished Medical Equipment Testing and Certification Under the NEC Refurbished Medical Equipment Testing and Certification Under the NEC
    Japan to Lead APAC Assisted Reproductive Technology Devices Market Japan to Lead APAC Assisted Reproductive Technology Devices Market
    Portescap Slotless Brushless DC Motors Receive ISO 13485 Certification Portescap Slotless Brushless DC Motors Receive ISO 13485 Certification
    FDA Breakthrough Device Designation Given to MI Transcatheter Heart Pump FDA Breakthrough Device Designation Given to MI Transcatheter Heart Pump

    Related Breaking News

    • Diagnostics
      EchoNous Expands Its Kosmos Hardware Platform

      EchoNous Expands Its Kosmos Hardware Platform

      Adds continuous wave and pulsed wave Doppler capabilities.
      Charles Sternberg, Assistant Editor 03.04.21

    • Cardiovascular
      Medtronic Begins Trial to Assess Novel Ablation Tech to Treat AFib

      Medtronic Begins Trial to Assess Novel Ablation Tech to Treat AFib

      Will evaluate PulseSelect's pulsed electrical fields to interrupt irregular heart rhythms.
      Sam Brusco, Associate Editor 03.04.21

    • Europe

      Europe's Cross-Border Medtech Deal Activity Rises in Q4 2020

      M&A was the most prolific of deal types.
      Michael Barbella, Managing Editor 03.04.21


    • Chronic Disease | Diagnostics
      Bio-Techne to Acquire Asuragen for $320M

      Bio-Techne to Acquire Asuragen for $320M

      Bio-Techne gains genetic carrier screening and oncology testing kits.
      Sam Brusco, Associate Editor 03.04.21

    • QUANTA Appoints Chief Operating Officer

      QUANTA Appoints Chief Operating Officer

      New executive has 15 years of experience, including a stint at Johnson & Johnson Medical Devices & Diagnostics.
      Michael Barbella, Managing Editor 03.04.21

    • BD Buys GSL Solutions to Broaden Medication Management

      BD Buys GSL Solutions to Broaden Medication Management

      GSL develops smart medication devices to store and track controlled substances.
      Sam Brusco, Associate Editor 03.04.21


    • Philips Partners With AI Software Provider for Better Workflow

      Philips Partners With AI Software Provider for Better Workflow

      The company will incorporate Lunit's chest detection suite into its diagnostic X-ray platform.
      Michael Barbella, Managing Editor 03.04.21

    • Plastikos Medical Begins Phase II of Expansion

      Plastikos Medical Begins Phase II of Expansion

      Will more than double the size of its current ISO-7 cleanroom.
      Charles Sternberg, Assistant Editor 03.03.21

    • Ready Robotics Hires Proven Automation Leaders

      Ready Robotics Hires Proven Automation Leaders

      Juan Aparicio and Mark Patterson join the company.
      Charles Sternberg, Assistant Editor 03.03.21


    • Diagnostics | Digital Health
      Philips, Disney Join Forces to Reduce Childrens

      Philips, Disney Join Forces to Reduce Childrens' MRI Anxiety

      Will explore effects and use of animated stories and characters, including Disney favorites, as part of Philips Ambient Experience solution.
      Sam Brusco, Associate Editor 03.03.21

    • Surgical
      FDA OKs Asensus

      FDA OKs Asensus' Senhance for General Surgery

      Indication expansion allows Senhance's use in high-value, complex reconstructive surgeries.
      Sam Brusco, Associate Editor 03.03.21

    • Surgical
      Boston Scientific to Buy Lumenis

      Boston Scientific to Buy Lumenis' Surgical Biz for $1B

      Gains laser systems, fibers, and accessories for urology and otolaryngology procedures.
      Sam Brusco, Associate Editor 03.03.21


    • Medtech M&A Total Deal Value Plummets in Q4 2020

      Medtech M&A Total Deal Value Plummets in Q4 2020

      But number of U.S. transactions rose 6.6 percent compared to the prior year's quarter.
      Michael Barbella, Managing Editor 03.03.21

    • Dexcom Launches Inaugural Venture Capital Fund

      Dexcom Launches Inaugural Venture Capital Fund

      Dexcom Ventures to identify and invest in transformational technologies to advance long-term growth.
      Michael Barbella, Managing Editor 03.03.21

    • FDA Clears HydroMID Midline Catheter From Access Vascular

      FDA Clears HydroMID Midline Catheter From Access Vascular

      Patented biomaterial used in catheter designed to reduce thrombus accumulation.
      Michael Barbella, Managing Editor 03.03.21


    Trending
    • Philips, Disney Join Forces To Reduce Childrens' MRI Anxiety
    • Plastikos Medical Begins Phase II Of Expansion
    • Hardy Diagnostics Releases Rapid Test For COVID-19
    • NAMSA Acquires American Preclinical Services
    • Ready Robotics Hires Proven Automation Leaders
    Breaking News
    • EchoNous Expands Its Kosmos Hardware Platform
    • Medtronic Begins Trial to Assess Novel Ablation Tech to Treat AFib
    • Europe's Cross-Border Medtech Deal Activity Rises in Q4 2020
    • Bio-Techne to Acquire Asuragen for $320M
    • QUANTA Appoints Chief Operating Officer
    View Breaking News >
    CURRENT ISSUE

    March 2021

    • Stressed Testing: Challenges with Medical Device Testing
    • Resourceful Resources: Materials Make a Difference During the Pandemic
    • Diagnostic Desperation: A Look at IVD Trends During COVID-19
    • Digitize Your QMS via an Enterprise Cloud Platform
    • Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    IFT Transitions 2021 Annual Event to Digital Experience
    NY Federal Judge Enters Permanent Injunction Against Dietary Supplement Manufacturer
    Statins May Contribute to Vascular Calcification by Inhibiting Vitamin K-Dependent Proteins
    Coatings World

    Latest Breaking News From Coatings World

    Chromaflo Technologies Adds Benjamin Woeste as Territory Sales Manager
    Maroon Group Acquires Cary Company's Raw Materials, Specialty Chemicals Distribution Business
    Matt Fogel Named Mule-Hide's Territory Manager – Southern Virginia
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    EchoNous Expands Its Kosmos Hardware Platform
    Medtronic Begins Trial to Assess Novel Ablation Tech to Treat AFib
    Europe's Cross-Border Medtech Deal Activity Rises in Q4 2020
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Amgen to Acquire Five Prime Therapeutics for $1.9B
    Genesis Drug Discovery & Development Acquires Integrated Analytical Solutions
    CureVac, Novartis Ink COVID Vax Mfg. Pact
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Estée Lauder Establishes Equity and Engagement Center of Excellence
    L'Oreal On How It Will Shape Beauty's Future at Today's Transparency Summit
    C.O. Bigelow Earns Praise as NYC's Oldest Family-Run Apothecary
    Happi

    Latest Breaking News From Happi

    The Fragrance Foundation Celebrates Fragrance Day
    China To End Animal Testing for Imported 'Ordinary' Cosmetics
    Avon Launches Vegan Skin Care Line
    Ink World

    Latest Breaking News From Ink World

    Massilly North America Adds Koenig & Bauer MetalStar 3 Metal Decorating Press
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Access Direct Mail Doubles Revenue with SCREEN's Truepress Jet520HD
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Henkel publishes 30th Sustainability Report
    Avery Dennison Smartrac launches new Circus Pro inlays
    Springfield Solutions highlights digital label embellishments
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    FPInnovations Develops Biodegradable Mask
    Sani Professional Sanitizing and Disinfecting Products Approved by EPA
    Autefa Solutions Offers Fully Automated Line for Protective Mask Production
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Bioventus Appoints Managing Director, China and Asia Pacific
    Full-Year Sales Down 12 Percent at Zimmer Biomet
    Lincotek Medical Expands Coatings and Additive Capacity
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login